30 results
424B3
RSLS
ReShape Lifesciences Inc.
13 Apr 21
Prospectus supplement
4:22pm
, and the safety systems Obalon designs into its products may not prevent all possible adverse events and injuries and/or Obalon’s products may fail to function … in January 2017, it has reported adverse events relating to patient injuries associated with use of the Obalon balloon in the FDA’s MAUDE database. To-date
S-4/A
RSLS
ReShape Lifesciences Inc.
9 Apr 21
Registration of securities issued in business combination transactions (amended)
5:20pm
, and the safety systems Obalon designs into its products may not prevent all possible adverse events and injuries and/or Obalon’s products may fail to function … in January 2017, it has reported adverse events relating to patient injuries associated with use of the Obalon balloon in the FDA’s MAUDE database. To-date
S-4
dkygpauagefke
30 Mar 21
Registration of securities issued in business combination transactions
12:00am
424B4
jm5s v1f22k3
5 Aug 19
Prospectus supplement with pricing info
12:00am
8-K
zpe s8omtdvnt
28 Jun 19
Other Events
4:09pm
8-K
EX-99.2
1n862w
24 Jun 19
Other Events
12:00am
8-K
EX-99.1
s42azu
24 Jun 19
Other Events
12:00am